• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.78% Nasdaq Down 1.13%

    Synta Pharmaceuticals Corp. (SNTA)

    -NasdaqGM
    0.41 Down 0.01(1.74%) 4:00PM EDT
    |After Hours : 0.41 0.00 (0.00%) 4:00PM EDT - Nasdaq Real Time Price
    Prev Close:0.41
    Open:0.42
    Bid:0.40 x 5000
    Ask:0.44 x 700
    1y Target Est:1.00
    Beta:0.875801
    Next Earnings Date:N/A
    Day's Range:0.40 - 0.42
    52wk Range:0.15 - 2.65
    Volume:555,072
    Avg Vol (3m):1,360,960
    Market Cap:55.87M
    P/E (ttm):N/A
    EPS (ttm):-0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SNTA

    Comparison

    Symbol% ChgMkt Cap
    SNTADown 1.74%55.87M
    INFIDown 3.92%278.57M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.07
    Quarterly EPS Est (Mar-16) :-0.03
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synta Pharmaceuticals Corp. focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. Its clinical stage drug candidate in oncology is ganetespib, an Hsp90 inhibitor, which is in Phase II clinical... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback